TMBIM4 and neurodegenerative disease: Therefore, memantine’s dual mechanism—through both direct NMDA receptor antagonism and indirect modulation via S1R—may exert synergistic neuroprotective effects, which are particularly relevant for the treatment of neurodegenerative diseases [103,105,106,117].